• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Doctor Sentenced to Six Months for Faking Study Results

Doctor Sentenced to Six Months for Faking Study Results

July 7, 2010
CenterWatch Staff

Scott Reuben, the Massachusetts doctor dubbed the medical equivalent of Bernie Madoff by Scientific American, was sentenced to six months in federal prison on June 24. His crime: faking favorable painkiller study results. Reuben pleaded guilty to one count of health care fraud in February.

The 51-year-old anesthesiologist, formerly chief of the acute pain clinic at Baystate Medical Center in Springfield, Mass., also got three years probation, and was ordered to pay a $5,000 fine and make restitution of $362,000 to the companies that gave him research grants. Those include Pfizer (for Bextra, Celebrex and Lyrica) and Merck (for Vioxx).

Reuben’s lawyers have since said he suffered from bipolar disorder.

Arthur Caplan, director of the Center for Bioethics at the University of Pennsylvania, said the sentence is significant.

“Lots of people just get their grants suspended and they move on and work somewhere else,” said Caplan. “It’s notable that they went after this guy. It’s a pretty clear message that there’s less tolerance of fraud and misconduct now.”

Baystate started to get suspicious about the pain-management thought leader in 2008 when the hospital conducted a routine internal audit and found that Reuben did not have institutional review board approval for two studies he was conducting. In March of 2009, Baystate announced that Reuben admitted he never conducted the clinical trials he wrote about in 21 journal articles. He’d been faking research since 1996.

Reuben even invented some patients and forged the names of “co-authors” on the journal articles—real researchers who had not participated in any research with Reuben. At least 13 of his studies published in journals had to be retracted.

Reuben was a paid member of the Pfizer’s speakers bureau, delivering talks about Pfizer drugs to other doctors. The company gave him five research grants between 2002 and 2007. 

Reuben, who went to medical school at State University of New York at Buffalo and completed his residency at Mount Sinai Medical Center in New York, no longer holds an appointment as a professor at Tufts University’s medical school, and his license status with the Massachusetts Board of Registration in Medicine is listed as “voluntary agreement not to practice.”

“These cases are hugely damaging to the clinical research process when they occur,” said Caplan. “They put patients at risk because medicines are given with false data and therefore an inadequate base of evidence. They waste taxpayers’ money. They cost a lot to weed out and detect, so it’s bad for universities that get stuck having to track this down.

And it’s bad for the reputation of clinical research. Happily, though, this is rare.”

Upcoming Events

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing